Active Ingredient: PALONOSETRON HYDROCHLORIDE
Proprietary Name: PALONOSETRON HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A206396
Product Number: 001
Approval Date: Sep 19, 2018
Applicant Holder Full Name: CIPLA LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information